{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:09:39Z","timestamp":1778544579703,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T00:00:00Z","timestamp":1694908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["MCIN\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021-127945OB-I00"],"award-info":[{"award-number":["PID2021-127945OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CB06\/04\/0071"],"award-info":[{"award-number":["CB06\/04\/0071"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011596","name":"Education Culture and Sports Department","doi-asserted-by":"publisher","award":["CIPROM\/2021\/044"],"award-info":[{"award-number":["CIPROM\/2021\/044"]}],"id":[{"id":"10.13039\/501100011596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011596","name":"Education Culture and Sports Department","doi-asserted-by":"publisher","award":["AICO2021\/017"],"award-info":[{"award-number":["AICO2021\/017"]}],"id":[{"id":"10.13039\/501100011596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["FPU19\/05064"],"award-info":[{"award-number":["FPU19\/05064"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","award":["FPU18\/02435"],"award-info":[{"award-number":["FPU18\/02435"]}],"id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","award":["FPU16\/05896"],"award-info":[{"award-number":["FPU16\/05896"]}],"id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019157","name":"Foundation for the Promotion of the Research in Healthcare and Biomedicine","doi-asserted-by":"publisher","award":["UGP-21-236"],"award-info":[{"award-number":["UGP-21-236"]}],"id":[{"id":"10.13039\/501100019157","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.biopha.2023.115537","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T05:02:51Z","timestamp":1695186171000},"page":"115537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Anti-inflammatory and immunomodulating effects of rilpivirine: Relevance for the therapeutics of chronic liver disease"],"prefix":"10.1016","volume":"167","author":[{"given":"Angela B.","family":"Moragrega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4411-829X","authenticated-orcid":false,"given":"Aleksandra","family":"Gruevska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Fuster-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Benedicto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1258-9513","authenticated-orcid":false,"given":"Joan","family":"Tosca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mont\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor M.","family":"Victor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan V.","family":"Esplugues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Blas-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4487-2471","authenticated-orcid":false,"given":"Nadezda","family":"Apostolova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115537_bib1","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","article-title":"Contemporary epidemiology of chronic liver disease and cirrhosis","volume":"18","author":"Moon","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115537_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115537_bib3","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115537_bib4","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-22-0194","article-title":"Treating inflammation to combat non-alcoholic fatty liver disease","volume":"256","author":"Wiering","year":"2022","journal-title":"J. Endocrinol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115537_bib5","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice","volume":"58","author":"Pradere","year":"2013","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.biopha.2023.115537_bib6","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.3390\/biomedicines10082035","article-title":"Mechanism and therapeutic targets of c-Jun-N-terminal kinases activation in nonalcoholic fatty liver disease","volume":"10","author":"Min","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2023.115537_bib7","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/hep.26783","article-title":"Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice","volume":"59","author":"Baeck","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2023.115537_bib8","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1136\/gutjnl-2013-306294","article-title":"CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis","volume":"63","author":"Ehling","year":"2014","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.biopha.2023.115537_bib9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/gutjnl-2019-318372","article-title":"Rilpivirine attenuates liver fibrosis through selective STAT1-mediated apoptosis in hepatic stellate cells","volume":"69","author":"Mart\u00ed-Rodrigo","year":"2020","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.biopha.2023.115537_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-04789-7","article-title":"Implication of autophagy in the antifibrogenic effect of Rilpivirine: when more is less","volume":"13","author":"Lucantoni","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2023.115537_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene expression Omnibus: NCBI gene expression and hybridization array data Repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2023.115537_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.biopha.2023.115537_bib13","first-page":"108","article-title":"CateGOrizer: a web-based program to batch analyze gene ontology classification categories","volume":"9","author":"Hu","year":"2008","journal-title":"Online J. Bioinforma."},{"issue":"6","key":"10.1016\/j.biopha.2023.115537_bib14","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jhep.2014.07.006","article-title":"CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis","volume":"61","author":"Zhang","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2023.115537_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.812431","article-title":"Functional roles of chemokine receptor CCR2 and its ligands in liver disease","volume":"13","author":"She","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115537_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158156","article-title":"Antifibrotic effects of the dual CCR2\/CCR5 antagonist cenicriviroc in animal models of liver and kidney fibrosis","volume":"11","author":"Lefebvre","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115537_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.874408","article-title":"New drugs for hepatic fibrosis","volume":"13","author":"Shan","year":"2022","journal-title":"Front Pharm."},{"issue":"23","key":"10.1016\/j.biopha.2023.115537_bib18","article-title":"Cenicriviroc lacked efficacy to treat liver fibrosis in nonalcoholic steatohepatitis: AURORA phase III randomized study","volume":"S1542\u20133565","author":"Anstee","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115537_bib19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1189\/jlb.0303093","article-title":"Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation","volume":"74","author":"Harvey","year":"2003","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115537_bib20","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jaut.2010.09.003","article-title":"CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation","volume":"35","author":"Hintermann","year":"2010","journal-title":"J. Autoimmun."},{"issue":"10","key":"10.1016\/j.biopha.2023.115537_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013577","article-title":"Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients","volume":"5","author":"Bertola","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115537_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101190","article-title":"Stress kinases in the development of liver steatosis and hepatocellular carcinoma","volume":"50","author":"Cicu\u00e9ndez","year":"2021","journal-title":"Mol. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2023.115537_bib23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3390\/cells10030501","article-title":"STAT6 signaling mediates PPAR\u03b3 activation and resolution of acute sterile inflammation in mice","volume":"10","author":"Lee","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biopha.2023.115537_bib24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2008.01.045","article-title":"Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice","volume":"584","author":"Zheng","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115537_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2119\/molmed.2016.00203","article-title":"Induction of steatohepatitis (NASH) with insulin resistance in wildtype B6 mice by a western-type diet containing soybean oil and cholesterol","volume":"23","author":"Henkel","year":"2017","journal-title":"Mol. Med."},{"issue":"9","key":"10.1016\/j.biopha.2023.115537_bib26","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1194\/jlr.M016246","article-title":"Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice","volume":"52","author":"Subramanian","year":"2011","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.biopha.2023.115537_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/biomedicines8020028","article-title":"NAFLD preclinical models: more than a handful, less of a concern?","volume":"8","author":"Oligschlaeger","year":"2020","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.biopha.2023.115537_bib28","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.2119\/molmed.2012.00223","article-title":"Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response","volume":"18","author":"Spruss","year":"2012","journal-title":"Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2023.115537_bib29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.22363","article-title":"Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis","volume":"48","author":"Wouters","year":"2008","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.biopha.2023.115537_bib30","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.3390\/nu11123067","article-title":"Nonalcoholic fatty liver disease induced by high-fat diet in C57bl\/6 models","volume":"11","author":"Recena Aydos","year":"2019","journal-title":"Nutrients"},{"issue":"26","key":"10.1016\/j.biopha.2023.115537_bib31","doi-asserted-by":"crossref","first-page":"8525","DOI":"10.3748\/wjg.v20.i26.8525","article-title":"High fat diet feeding results in gender specific steatohepatitis and inflammasome activation","volume":"20","author":"Ganz","year":"2014","journal-title":"World J. Gastroenterol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:19:23Z","timestamp":1778541563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223013355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":31,"alternative-id":["S0753332223013355"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115537","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory and immunomodulating effects of rilpivirine: Relevance for the therapeutics of chronic liver disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115537","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115537"}}